Authors stated that the intranasal (IN) route offers an alternative approach for drug delivery to the brain and represents an easier access for the treatment of Alzheimer's disease (AD).
The drugs follow intracellular and extracellular transport mechanism to enter into the different regions of the brain via olfactory and trigeminal sensory neurons, but the exact mechanism of drug transport from the nasal cavity to the brain is still discussed. This delivery device is able to directly target the drug to the olfactory region of the nasal cavity which further facilitates the absorption of the drug through neuronal channels; this feature can make the drug bioavailability in the brain more uniform and reproducible (use of various additives, nature of the drug, formulation parameters, experimental conditions) than the current strategies. * Other studies on different drugs (e.g. melanocortins peptides) are under intensive investigation for AD. These researches should be quoted to improve the manuscript.
